A placebo-controlled trial of lamotrigine for painful HIV-associated neuropathy

Neurology

Volumn 54, Issue 11, 2000, Pages 2115-2119

  Simpson, D M ^a   Olney, R ^b   McArthur, J C ^c   Khan, A ^a   Godbold, J ^a   Ebel Frommer, K ^a  

^a MOUNT SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

AIDS; HIV; Lamotrigine; Neuropathy

Indexed keywords

ANTICONVULSIVE AGENT; LAMOTRIGINE;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MULTICENTER STUDY; NEUROPATHY; PAIN ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH;

EID: 0034643845     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.54.11.2115     Document Type: Article

References (20)

1. Simpson D, Olney RK. Peripheral neuropathies associated with human immunodeficiency virus infection. In: Dyck PJ, ed. Peripheral neuropathies: new concepts and treatments. Philadelphia: Saunders, 1992:685-711.
2. The Dana Consortium on Therapy for HIV Dementia and Related Cognitive Disorders. Clinical confirmation of the American Academy of Neurology algorithm for HIV-1 associated cognitive/motor disorder. Neurology 1996;47:1247-1253.
3. DeLeo JA, Colburn RW, Rickman AJ. Cytokine and growth factor immunohistochemical spinal profiles in two animal models of mononeuropathy. Brain Res 1997;759:50-57.
4. Berger AR, Arezzo JC, Schaumberg HH, et al. 2′,3′-Dideoxycytidine (ddC) toxic neuropathy: a study of 52 patients. Neurology 1993;43:358-362.
5. Simpson DM, Tagliati M. Nucleoside analogue-associated peripheral neuropathy in human immunodeficiency virus infection. J Acquir Immune Defic Syndrome 1995;9:153-161.
6. Simpson DM, Dorfman D, Olney RK, Peptide T Neuropathy Study Group. Peptide T in the treatment of painful distal neuropathy associated with AIDS: results of a placebo-controlled trial. Neurology 1996;47:1254-1259.
7. Newshan G. HIV neuropathy treated with gabapentin. AIDS 1998;12:219-221. Letter.
8. Rosner H, Rubin L, Kestenbaum A. Gabapentin adjunctive therapy in neuropathic pain states. Clin J Pain 1996;12:56-58.
9. Kieburtz K, Simpson D, Yiannoutsos C, AIDS Clinical Trial Group 242 Protocol Team. A randomized trial of amitriptyline and mexiletine for painful neuropathy in HIV Infection. Neurology 1998;51:1682-1688.
10. McArthur JC, Yiannoutsos C, Simpson DM, ACTG Team 291. A phase II trial of nerve growth factor for sensory neuropathy associated with HIV infection. Neurology 2000;54: 1080-1088.
11. Larkin M. Nerve growth factor promising in diabetic neuropathy and in HIV-1-related neuropathy. Lancet 1998;352:1039.
12. Gomez-Perez FJ, Choza R, Rios JM, et al. Nortriptyline-fluphenazine vs. carbamazepine in the symptomatic treatment of diabetic neuropathy. Arch Med Res 1996;27:525-529.
13. Kingery WS. A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes. Pain 1997;73:123-139.
14. Power C, Moench T, Peeling J, Kong PA, Langelier T. Feline immunodeficiency virus causes increased glutamate levels and neuronal loss in brain. Neuroscience 1997;77: 1175-1185.
15. Zakrzewska JM, Chaudry Z, Nurmikko TJ, Patton DW, Mullens EL. Lamotrigine (Lamictal) in refractory trigeminal neuralgia: results from a double-blind placebo controlled cross-over trial. Pain 1997;73:223-230.
16. Gracely RH, McGrath P, Dubner R. Ratio scales of sensory and affective verbal pain descriptors. Pain 1978;5:5-18.
17. Diggle PJ, Liang K-Y, Zeger SL. Analysis of longitudinal data. New York: Oxford Science Publications, 1994.
18. Shlay JC, Chaloner K, Max MB, et al. Acupuncture and amitriptyline for pain due to HIV-related peripheral neuropathy. JAMA 1998;280:1590-1595.
19. Brodie MJ. Lamotrigine - an update. Can J Neurol Sci 1996; 23:S6-S9.
20. Ryan C, Madalon M, Wortham DW, Graziano FM. Sulfa hypersensitivity in patients with HIV infection: onset, treatment, critical review of the literature. WMJ 1998;97:23-27.